Prokidney (PROK) Tax Provisions (2021 - 2025)
Prokidney (PROK) posted quarterly Tax Provisions of -$33.8 million for Q4 2025, down 2083.02% year-over-year from $1.7 million in Q4 2024, and down 6126.96% quarter-over-quarter from $560000.0 in Q3 2025.
Prokidney (PROK) Tax Provisions (2021 - 2025) Analysis & Trends
Prokidney (PROK) has reported Tax Provisions for 5 consecutive years, with -$33.8 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Tax Provisions fell 2083.02% year-over-year to -$33.8 million; the TTM figure through Mar 2026 stood at -$32.3 million (down 30702.86% YoY), while the FY2025 annual figure was -$31.8 million, down 5209.7% from the prior year.
- Tax Provisions retreated to -$33.8 million in Q4 2025 per PROK's latest filing, from $560000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $2.8 million in Q4 2023 and bottomed at -$33.8 million in Q4 2025.
- Historically, Tax Provisions has averaged -$1.4 million across 5 years, with a median of $575500.0 in 2025.
- On a YoY basis, Tax Provisions climbed as much as 1614.29% in 2025 and fell as far as 2083.02% in 2025.
- Prokidney's Tax Provisions stood at $114000.0 in 2021, then tumbled by 1207.02% to -$1.3 million in 2022, then jumped by 321.16% to $2.8 million in 2023, then slumped by 39.02% to $1.7 million in 2024, then tumbled by 2083.02% to -$33.8 million in 2025.
- Business Quant data shows PROK's Tax Provisions at -$33.8 million in Q4 2025, $560000.0 in Q3 2025, and $848000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Prokidney | 679.95 Mn | 679.95 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -33.75 Mn |
| Sep 30, 2025 | 560,000.00 |
| Jun 30, 2025 | 848,000.00 |
| Mar 31, 2025 | 591,000.00 |
| Dec 31, 2024 | 1.70 Mn |
| Sep 30, 2024 | -2.34 Mn |
| Jun 30, 2024 | -56,000.00 |
| Mar 31, 2024 | 98,000.00 |
| Dec 31, 2023 | 2.79 Mn |
| Sep 30, 2023 | 913,000.00 |
| Jun 30, 2023 | 965,000.00 |
| Mar 31, 2023 | 1.33 Mn |
| Dec 31, 2022 | -1.26 Mn |
| Sep 30, 2022 | -75,000.00 |
| Jun 30, 2022 | 1.22 Mn |
| Mar 31, 2022 | 1.01 Mn |
| Dec 31, 2021 | 114,000.00 |
| Sep 30, 2021 | -60,000.00 |